3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
8
Unknown
2
Withdrawn
1
Sponsor Class
NETWORK
1
Study Type
Interventional
1
Sponsor
Cancer Type
Head & Neck
1
Conditions
Carcinoma, Non-Small-Cell Lung
16
Lung Neoplasms
10
Breast Neoplasms
10
Uterine Cervical Neoplasms
9
Lymphoma
8
Squamous Cell Carcinoma of Head and Neck
7
Prostatic Neoplasms
7
Precursor Cell Lymphoblastic Leukemia-Lymphoma
7
Head and Neck Neoplasms
7
Lymphoma, Large B-Cell, Diffuse
6
Sarcoma
5
Melanoma
5
Lymphoma, Follicular
5
Leukemia
5
Colorectal Neoplasms
5
Adenocarcinoma of Lung
5
Small Cell Lung Carcinoma
4
Rectal Neoplasms
4
Lymphoma, Non-Hodgkin
4
Lymphoma, Mantle-Cell
4
Lymphoma, Large-Cell, Immunoblastic
4
Lymphoma, B-Cell, Marginal Zone
4
Leukemia, Myeloid, Acute
4
Leukemia, Lymphocytic, Chronic, B-Cell
4
Glioblastoma
4
Central Nervous System Neoplasms
4
Carcinoma, Hepatocellular
4
Burkitt Lymphoma
4
Ovarian Neoplasms
3
Neoplasms
3
Interventions
Docetaxel
3
Gene Expression Profiling
2
vandetanib
1
Therapeutics
1
Taxes
1
Radiotherapy
1
Polymerase Chain Reaction
1
Microarray Analysis
1
Immunohistochemistry
1
Hypericum extract LI 160
1
Everolimus
1
Erlotinib Hydrochloride
1
Electrophoresis, Polyacrylamide Gel
1
Cisplatin
1
Carboplatin
1
Biopsy
1
3-(5-fluorobenzofuran-3-yl)-4-(5-methyl-5H-(1,3)dioxolo(4,5-f)indol-7-yl)-pyrrole-2,5-dione
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Withdrawn
×
Salivary Gland Neoplasms
×
Radiotherapy
×
Clear all
NCT00084435
2012-06-14
S0217
SWOG Cancer Research Network
Phase 2
Withdrawn